Clinical trial

Effects of Exenatide in Type 2 Diabetic Patients With Congestive Heart Failure

NCT00766857

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Mapped RxNorm record exenatide Normalized identity: exenatideView linked drug · Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Insulin glargine Normalized identity: insulin glargineView linked drug · Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Effects of Exenatide in Type 2 Diabetic Patients With Congestive Heart Failure

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE4

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2009-05-01

PhasePHASE4

Conditions

Type 2 Diabetes Mellitusverified · MONDO: type 2 diabetes mellitus

Congestive Heart Failureverified · MONDO: congestive heart failure

Interventions

exenatideDRUG · verified · RxNorm: exenatide

Insulin glargineDRUG · verified · RxNorm: insulin glargine

Sponsors & collaborators

Amsterdam UMC, location VUmclead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00766857 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.